tradingkey.logo

Immunoprecise Antibodies Ltd

IPA
Detailliertes Diagramm anzeigen
2.070USD
0.0000.00%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
95.54MMarktkapitalisierung
VerlustKGV TTM

Immunoprecise Antibodies Ltd

2.070
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Heute

0.00%

5 Tage

0.00%

1 Monat

0.00%

6 Monate

+9.52%

Seit Jahresbeginn

0.00%

1 Jahr

+307.48%

Detailliertes Diagramm anzeigen

TradingKey Aktien-Score

Kein Aktien-Score verfügbar aufgrund unzureichender Daten.

Immunoprecise Antibodies Ltd Nachrichten

Bald gibt es mehr Neuigkeiten, bleiben Sie dran...

Finanzindikatoren

EPS

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Gesamteinnahmen

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Immunoprecise Antibodies Ltd Informationen

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
BörsenkürzelIPA
UnternehmenImmunoprecise Antibodies Ltd
CEODr. Jennifer Lynne Bath, Ph.D.
Websitehttps://www.ipatherapeutics.com/
KeyAI